3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Primary Myelofibrosis
13
Myeloproliferative Disorders
9
Leukemia, Myeloid, Acute
8
Thrombocythemia, Essential
6
Polycythemia Vera
6
Myelodysplastic Syndromes
5
Leukemia
5
Recurrence
3
Neoplasms
3
Lymphoma, T-Cell
3
Graft vs Host Disease
3
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma
2
Leukemia, Prolymphocytic, T-Cell
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Hematologic Neoplasms
2
Uveal Melanoma
1
Thalassemia
1
Targeted Therapy
1
Prostatic Neoplasms
1
Preleukemia
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Neoplasms by Histologic Type
1
Mycosis Fungoides
1
Multiple Myeloma
1
Mesothelioma
1
Melanoma
1
Lymphoma, T-Cell, Peripheral
1
Interventions
Gemcitabine
58
130-nm albumin-bound paclitaxel
35
Specimen Handling
26
Fluorouracil
22
Albumin-Bound Paclitaxel
22
Magnetic Resonance Spectroscopy
21
Leucovorin
21
Irinotecan
21
Oxaliplatin
19
Biopsy
17
Taxes
16
pembrolizumab
15
Cyclophosphamide
12
Cisplatin
11
fludarabine
10
Cetuximab
9
Capecitabine
8
durvalumab
7
Radiosurgery
7
Nivolumab
7
Carboplatin
7
irinotecan sucrosofate
6
dehydroftorafur
6
Pemetrexed
6
olaparib
5
Radiotherapy
5
Ipilimumab
5
Erlotinib Hydrochloride
5
Blood Specimen Collection
5
trastuzumab deruxtecan
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pancreatic Neoplasms
×
ruxolitinib
×
90 days
×
Clear all
No trials found.